Betco Agrees to Purchase Assets of NovozymesOctober 4, 2022
The transaction is subject to customary closing conditions and adjustments and will be Betco’s second acquisition in the bioaugmentation field. The company purchased EnviroZyme® in 2015. The transaction will be fully funded at the anticipated closing date during the first quarter of 2023.
“Novozymes has an outstanding portfolio of wastewater customers and product solutions that complements our existing EnviroZyme business and facilitates access into new markets globally,” said Toby Jercovich, Betco chief financial officer. “This acquisition will allow us to immediately fulfill a strategic growth initiative and provides a significant opportunity for long-term, accretive earnings.”
Toledo, Ohio-based Betco Corp. has been manufacturing commercial and institutional cleaning products since 1950. For more information, visit www.betco.com.
Novozymes is a biotech company with a strong focus on enzyme production. Novozymes manufactures more than 700 biotechnology products in 130 countries. For more information, visit www.novozymes.com.